After finishing at $0.13 in the prior trading day, Oblong Inc (NASDAQ: OBLG) closed at $0.13, down -1.49%. On the day, 546448 shares were traded.
Ratios:
Our goal is to gain a better understanding of OBLG by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.76 and its Current Ratio is at 4.93. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Oct 24 ’23 when ADELMAN JASON T sold 52,191 shares for $0.18 per share. The transaction valued at 9,655 led to the insider holds 0 shares of the business.
Meredith Deborah Jean sold 7,373 shares of OBLG for $10,504 on Jun 16 ’23. The Director now owns 0 shares after completing the transaction at $1.42 per share. On Jun 15 ’23, another insider, Meredith Deborah Jean, who serves as the Director of the company, sold 3,671 shares for $1.51 each. As a result, the insider received 5,530 and left with 7,673 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 0.55 while its Price-to-Book (P/B) ratio in mrq is 0.38.
Stock Price History:
Over the past 52 weeks, OBLG has reached a high of $3.94, while it has fallen to a 52-week low of $0.11.
Shares Statistics:
A total of 16.68M shares are outstanding, with a floating share count of 16.55M. Insiders hold about 0.79% of the company’s shares, while institutions hold 1.98% stake in the company.
Earnings Estimates
Its stock is currently analyzed by FibroBiologics, Inc. different market analysts. The consensus estimate for the next quarter is $1.61, with high estimates of $0.00 and low estimates of $0.13.
Analysts are recommending an EPS of between $Financial Services and $Technology for the fiscal current year, implying an average EPS of $Healthcare.
